Search Results

, and perhaps neuropsychologic testing are important steps in the evaluation and treatment of these symptoms. 1 Organic brain pathology can cause psychiatric symptoms, 29 such as pseudobulbar affect in patients with ECD. 9 , 30 This neurologic

This was a hands-on multidisciplinary workshop in which clinicians, scientists, and advocacy partners met to discuss areas requiring further development, including understanding patients’ needs, deciphering the molecular pathology of adult

with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology . J Mol Diagn 2012 ; 14 : 525 – 540 . 15. Manolio TA Chisholm RL Ozenberger B . Implementing genomic medicine in the clinic: the future is

Grade and Depth of Myometrial Invasion Pathology A key component of the added value of SLN procedures in endometrial cancer is enhanced pathology, also known as ultrastaging . At the authors’ institution, the protocol for SLN evaluation is

and F-18 fluciclovine PET scans may help distinguish patients with indolent versus occult metastatic disease. Figure 1 illustrates the interaction between clinical disease features, family history, and pathology to determine who should be offered

personal connection, critical for a trusting and supportive relationship. Then, from various digital sources, we must evaluate pathology, genomics, imagining, and laboratory results to characterize our patient's condition. Then I use my knowledge and

the gastric cancer study in surgery and pathology. I. Clinical classification . Jpn J Surg 1981 ; 11 : 127 – 139 . 38 Soga J Kobayashi K Saito J . The role of lymphadenectomy in curative surgery for gastric cancer . World J Surg 1979

the data used to derive the model? Because nomograms are typically developed from retrospective data (with their inherent selection and reporting biases), the quality of the native data must be understood (e.g., was a central pathology review performed

addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathology complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Aliance) . J Clin

used for concurrent CRT, including cisplatin/etoposide, carboplatin/paclitaxel, cisplatin/vinblastine, and, for nonsquamous pathology, carboplatin or cisplatin with pemetrexed. 7 The carboplatin/paclitaxel regimen is given weekly with radiation therapy